EGFR and non-small cell lung carcinoma: An additional biosensing assay utilizing SPR imaging (SPRi) was invented by Fan et al. A modified Au chip containing antibodies (anti-CD63/anti-EGFR/anti-EpCAM) and various recognition sites enabled the multiplex characterization of EXOs derived from NSCLC via bio-affinity interactions.